EGINX | VEURX | EGINX / VEURX | |
Total Expense Ratio | 1.33 | 0.24 | 554% |
Annual Report Gross Expense Ratio | 1.33 | 0.24 | 554% |
Fund Existence | 22 years | 35 years | - |
Gain YTD | 14.345 | 21.695 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 433M | 32.4B | 1% |
Annual Yield % from dividends | 3.29 | 2.75 | 120% |
Returns for 1 year | -2.97 | 9.80 | -30% |
Returns for 3 years | 13.80 | 29.55 | 47% |
Returns for 5 years | 10.48 | 47.73 | 22% |
Returns for 10 years | 11.03 | 43.61 | 25% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FBT | 164.68 | 2.68 | +1.66% |
First Trust NYSE Arca Biotech ETF | |||
IWV | 340.96 | 3.69 | +1.09% |
iShares Russell 3000 ETF | |||
PEZ | 95.13 | 0.64 | +0.67% |
Invesco DW Consumer Cyclicals Momt ETF | |||
IBTM | 22.52 | -0.16 | -0.71% |
iShares iBonds Dec 2032 Term Trs ETF | |||
SMOG | 108.58 | -0.99 | -0.90% |
VanEck Low Carbon Energy ETF |